MannKind Corp
MNKD
#6155
Rank
NZ$1.88 B
Marketcap
NZ$5.86
Share price
-3.80%
Change (1 day)
-31.25%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -NZ$84.88 Million

According to MannKind Corp's latest financial reports the company's current earnings are NZ$0.39 Billion. In 2025 the company made an earning of NZ$2.5 Million a decrease over its 2024 earnings that were of NZ$54.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$84.88 Million-3485.15%
2025 NZ$2.5 M-95.39%
2024 NZ$54.38 M-394.09%
2023 -NZ$18.5 Million-88.13%
2022 -NZ$0.16 Billion8%
2021 -NZ$0.15 Billion40.84%
2020 -NZ$0.11 Billion10.7%
2019 -NZ$92.49 Million-40.16%
2018 -NZ$0.16 Billion-26.04%
2017 -NZ$0.21 Billion-193.33%
2016 NZ$0.22 B-134.11%
2015 -NZ$0.66 Billion85.72%
2014 -NZ$0.36 Billion3.6%
2013 -NZ$0.35 Billion12.79%
2012 -NZ$0.31 Billion5.58%
2011 -NZ$0.29 Billion-5.72%
2010 -NZ$0.31 Billion-22.51%
2009 -NZ$0.4 Billion-27.37%
2008 -NZ$0.54 Billion3.36%
2007 -NZ$0.53 Billion27.18%
2006 -NZ$0.42 Billion101.63%
2005 -NZ$0.21 Billion50.46%
2004 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.30 B-14,296.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$41.37 B-47,826.60%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$59.86 B-69,150.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.70 B-15,905.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$1.03 B-1,298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA